Skip to main content

Want a detailed portfolio tracker?

SGHT
NASDAQ
$5.04

Sight Sciences Inc (SGHT)

Sight Sciences Inc. (SGHT) is an innovative medical technology company specializing in the advancement of treatments for ocular diseases, with a particular emphasis on glaucoma management through both surgical and non-surgical approaches. The company’s diverse product portfolio, supported by a robust intellectual property framework, positions it favorably as demand for minimally invasive ophthalmic therapies escalates. By focusing on enhancing patient outcomes and refining its distribution network, Sight Sciences is set to capture significant market share in the evolving healthcare landscape, making it a noteworthy opportunity for institutional investors seeking growth in the medical technology sector.
Website: https://www.sightsciences.com
68 analysts
Buy
Target: $8.75 (+73.61%)

Market Cap

$284M

Free Cash Flow Yield

-9.06%

Beta (5Y)

1.58

Price Chart

Valuation
Market Cap$284M
P/S3.59
P/B5.10
Profitability
Total Revenue (TTM)$80M
Gross Profit (TTM)$69M
EBITDA-$35M
Profit Margin-65.9%
Operating Margin-63%
EPS-$0.70
Financial Health
Debt-to-Equity75.2%
Free Cash Flow Yield-9.06%
Growth & Risk
Revenue 5Y CAGR+17.01%
Beta (5Y)1.58
Sharpe Ratio0.78